- Total Q3 revenue rose 10% YoY to $24.0M with diagnostic revenue up 16%
- Net loss narrowed slightly to $8.0M ($0.75 per share) vs $8.7M in prior year
- Full-year revenue guidance revised to $101M-$103M with persistent operational burn
Signal #149895 · SEC 8-K
$BDSX SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $BDSX filing catalyst
Why did $BDSX trigger an AI stock catalyst alert?
$BDSX triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -1.5/10). Headline: Biodesix Reports Q3 Revenue of $24.0M (+10%), Net Loss of $8.0M, Revises FY Guidance. Key points: - Total Q3 revenue rose 10% YoY to $24.0M with diagnostic revenue up 16% - Net loss narrowed slightly to $8.0M ($0.75 per share) vs $8.7M in prior year - Full-year revenue guidance revised to $101M-$103M with persistent operational burn
How did $BDSX stock react after the SEC filing?
After the SEC 8-K for $BDSX, observed market reaction: T0 price $19.84. Past moves do not guarantee future results.
Where can I get real-time $BDSX SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $BDSX via Telegram and the VIP Web Terminal from €10/month.